• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Oxiconazole Nitrate

Oxiconazole Nitrate

Product ID O9234
Cas No. 64211-46-7
Purity ≥98%
Product Unit SizeCostQuantityStock
250 mg $68.00 In stock
1 g $135.00 In stock
5 g $398.00 In stock
25 g $1,081.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Oxiconazole is an imidazole antifungal and anti-parasitic compound. Oxiconazole inhibits ergosterol synthesis, preventing formation of cell walls and displaying antimicrobial activity against Candida and Leishmania.

Product Info

Cas No.

64211-46-7

Purity

≥98%

Formula

C18H13Cl4N3O • HNO3

Formula Wt.

492.15

Chemical Name

(Z)-1-(2,4-Dichloropheyl)-2-(1H-imidazol-1-yl)- ethenone O-[(2,4)-dichlorophenyl)methyl]oxime mononitrate

IUPAC Name

(Z)-1-(2,4-dichlorophenyl)-N-[(2, 4-dichlorophenyl)methoxy]-2-imidazol-1-ylethanimine;nitric acid

Synonym

Oxistat, Myfungar, Oceral

Melting Point

137-138°C

Solubility

Soluble in methanol.

Appearance

Yellowish to white crystalline powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

O9234 MSDS PDF

Info Sheet

O9234 Info Sheet PDF

References

Kalra MG, Higgins KE, Kinney BS. Intertrigo and secondary skin infections. Am Fam Physician. 2014 Apr 1;89(7):569-73. PMID: 24695603.

Jerajani HR, Amladi ST, Bongale R, et al. Evaluation of clinical efficacy and safety of once daily topical administration of 1% oxiconazole cream and lotion in dermatophytosis : an open label, non comparative multicentre study. Indian J Dermatol Venereol Leprol. 2000 Jul-Aug;66(4):188-92. PMID: 20877072.

Gebre-Hiwot A, Frommel D. The in-vitro anti-leishmanial activity of inhibitors of ergosterol biosynthesis. J Antimicrob Chemother. 1993 Dec;32(6):837-42. PMID: 8144423.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • B9700

    BYL719

    p110α PI3K inhibitor.

    ≥99%, ≥99%ee
  • N1979

    Neuromedin

    Endogenous proneurotensin peptide, involved in ...

    ≥95%
  • S6129

    D-Sphingosine

    Endogenous component of sphingolipids; PKC inhi...

    ≥98%
  • L1817

    Leflunomide

    AhR agonist, dihydroorotate dehydrogenase inhib...

    ≥98%
  • K3352

    Kinetensin

    Peptide, neurotensin analog.

    ≥95%
  • C8112

    CUDC-907

    PI3K and HDAC inhibitor.

    ≥98%
  • L1628

    Ac-LEHD-pNa

    Caspase 9 substrate.

    ≥95%
  • V0244

    Valganciclovir Hydrochloride

    Nucleoside (deoxyguanosine) analog, ganciclovir...

    ≥98%
  • K1776

    Ketotifen Fumarate

    H1 histamine and LT antagonist, PDE inhibitor.<...

    ≥98%
  • T0152

    Tandutinib

    FLT3, PDGFR, c-Kit inhibitor.

    ≥98%
  • G4480

    Glucagon, human

    Endogenous peptide hormone, counteracts insulin...

    ≥95%
  • K1655

    Kenpaullone

    GSK-3β, HGK, and CDK inhibitor.

    ≥95%
  • H9614

    Hydrochlorothiazide

    Thiazide diuretic; NCCT inhibitor, carbonic anh...

    ≥98%
  • V3345

    Vildagliptin

    DPP4 inhibitor.

    ≥97%
  • B0110

    Baclofen

    GABA derivative; GABA-B agonist.

    ≥98%
  • D5792

    Doxofylline

    Xanthine derivative; PDE inhibitor.

    ≥98%
  • M3196

    MHY-1485

    mTOR activator.

    ≥98%
  • M1769

    Meropenem Trihydrate

    β-lactam carbapenem; penicillin binding protei...

    ≥98%
  • J0240

    JAK2 Inhibitor V

    JAK2 inhibitor.

    ≥98%
  • V1668

    Vemurafenib

    B-Raf inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only